Answers are grounded in this paper and cite their sources.
#### The bottom line Overt hepatic encephalopathy affects approximately 20% of patients with liver cirrhosis each year.1 It is a pathognomonic feature of liver failure and a common cause of admission to emergency departments. It affects the quality of life of both patient and relatives2 and signifies a poor prognostic indicator for patients with cirrhosis, with a survival of only 23% at three years from onset.3 Treatments aimed at interrupting the pathogenesis of hepatic encephalopathy are known to reduce frequency of hospital admissions and improve survival.4 Studies suggest that the prevalence of chronic liver disease in the United Kingdom is increasing, in part owing to the increasing prevalence of non-alcoholic fatty liver disease (NAFLD), alcohol related liver disease, and hepatitis C.5 6 Clinicians therefore need to be able to recognise signs and symptoms of hepatic encephalopathy in patients who might not have a diagnosis of chronic liver disease. This review aims to highlight the importance of recognising hepatic encephalopathy in chronic liver failure and outlines a practical and evidence based approach to its management, based on the framework of recent guidelines from the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD).4 Hepatic encephalopathy in acute liver failure is managed differently, and will not be addressed. #### Sources and selection criteria We searched …
No takes yet. Share an insight, caveat, or question.
Ellul et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: